Innovative Development by an Israeli Company, Device for Cryodestruction of Breast Cancer

The new innovative device allows for the gentle removal of breast tumours.

When removing breast tumours, it is important to preserve not only the health of the patient but also the aesthetic appearance of the breast. The new innovative method of treating benign and malignant formations, cryodestruction, allows for the destruction of the tumour while minimally damaging the breast tissue.

Fast, Precise, Safe

The Israeli company IceCure Medical has released a device that has become a breakthrough in the treatment of breast tumours through cryodestruction. The IceSense3 device effectively handles the removal of small-sized neoplasms, almost without damaging the surrounding healthy tissues.

Cryodestruction, a method of tumour removal using deep freezing, does not require long rehabilitation and full anesthesia for the patient. IceSense3 has shown its effectiveness in removing fibroadenomas, benign tumours. The device acts on the tumour locally, destroying pathological cells within the tissues.

Initial Successes of IceSense3

A representative of a Japanese medical center, Dr. Aisuke Fukuma, specializing in breast cancer therapy, conducted a series of studies that demonstrated the effectiveness of IceSense3 in treating malignant breast cancer. Four patients with early-stage breast cancer underwent cryodestruction using the latest device. The surgeries were successful, allowing for the removal of the formation while minimizing damage to the breast tissue. The successes in treating breast neoplasms using the new device from IceCure Medical are confirmed by the recognition of the quality of IceSense3 in Europe. Currently, this Israeli corporation has established a subsidiary in the USA.

Cryodestruction using IceSense3 is a new chapter in the treatment of breast cancer, giving patients a chance not only to get rid of the disease but also to maintain the external attractiveness of the breast after tumour removal.